EMA recommends Gilead Sciences' Lenacapavir for HIV prevention, with FDA approval and generic options available soon.

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission.

The EU has approved an injectable HIV drug offering a two-month dosage schedule, marking a breakthrough in treatment ...

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...